Formulation and Evaluation of Medicated Tolnaftate Nail Lacquer

1
Farsana .P
Farsana .P
2
Baby Shahanas
Baby Shahanas
3
Anu Sebastian
Anu Sebastian
4
Ashly Merin George
Ashly Merin George

Send Message

To: Author

GJMR Volume 18 Issue B5

Article Fingerprint

ReserarchID

PDDTM4JVS5

Formulation and Evaluation of Medicated Tolnaftate Nail Lacquer Banner
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

The present study was aimed towards the design and formulation of medicated nail lacquer of tolnaftate to control onychomycosis condition and improve the patient compliance. The present work investigated the amount of tolnaftate released from different formulations containing different concentration of ethyl cellulose and different proportions of thioglycolic acid and dimethyl sulfoxides for treatment of onychomycosis. Then these lacquers were compared for drying time, nonvolatile content, drug content, drug diffusion and antimicrobial studies. The stability test showed that the formulation were stable at 37° ± 2°C for 1 month. The results obtained from in-vitro diffusion studies showed that formulation F3 have completed drug release of 94.48% over 24 hrs. The F3 formulation had salicylic acid as keratolytic agent and 0.5ml of 1% w/v of thioglycolic acid as penetration enhancer. From diffusion studies, it was concluded that thioglycolic acid containing formulation (F2 and F3) have better penetration enhancement as compared to DMSO containing formulation. The best formulation was evaluated for antifungal sensitivity test against the Candida albicans. From the above study, it can be concluded that medicated nail lacquers proved to be a better tool.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

Farsana .P. 2019. \u201cFormulation and Evaluation of Medicated Tolnaftate Nail Lacquer\u201d. Global Journal of Medical Research - B: Pharma, Drug Discovery, Toxicology & Medicine GJMR-B Volume 18 (GJMR Volume 18 Issue B5): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-B Classification: NLMC Code: QV 752
Version of record

v1.2

Issue date

January 4, 2019

Language

English

Experiance in AR

The methods for personal identification and authentication are no exception.

Read in 3D

The methods for personal identification and authentication are no exception.

Article Matrices
Total Views: 2821
Total Downloads: 1308
2026 Trends
Research Identity (RIN)
Related Research

Published Article

The present study was aimed towards the design and formulation of medicated nail lacquer of tolnaftate to control onychomycosis condition and improve the patient compliance. The present work investigated the amount of tolnaftate released from different formulations containing different concentration of ethyl cellulose and different proportions of thioglycolic acid and dimethyl sulfoxides for treatment of onychomycosis. Then these lacquers were compared for drying time, nonvolatile content, drug content, drug diffusion and antimicrobial studies. The stability test showed that the formulation were stable at 37° ± 2°C for 1 month. The results obtained from in-vitro diffusion studies showed that formulation F3 have completed drug release of 94.48% over 24 hrs. The F3 formulation had salicylic acid as keratolytic agent and 0.5ml of 1% w/v of thioglycolic acid as penetration enhancer. From diffusion studies, it was concluded that thioglycolic acid containing formulation (F2 and F3) have better penetration enhancement as compared to DMSO containing formulation. The best formulation was evaluated for antifungal sensitivity test against the Candida albicans. From the above study, it can be concluded that medicated nail lacquers proved to be a better tool.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]
×

This Page is Under Development

We are currently updating this article page for a better experience.

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Formulation and Evaluation of Medicated Tolnaftate Nail Lacquer

Farsana .P
Farsana .P
Baby Shahanas
Baby Shahanas
Anu Sebastian
Anu Sebastian
Ashly Merin George
Ashly Merin George

Research Journals